These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 15366587)

  • 1. [Clinical study on treatment of postmenopausal osteoporosis by Yigu capsule].
    Zhang RH; Chen KJ; Lu DX
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2004 Aug; 24(8):680-4. PubMed ID: 15366587
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A clinical study of Yigu capsule in treating postmenopausal osteoporosis.
    Zhang RH; Chen KJ; Lu DX; Zhu XF; Ma XC
    Chin J Integr Med; 2005 Jun; 11(2):97-103. PubMed ID: 16150195
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of correlation between blood biochemical indicators and bone mineral density of post-menopausal women.
    Liu SZ; Tian LF; Xu P; Zhuang GH; Zheng F; Tian J; Ning QL; Zhu BF; Lu SM; Yan H
    Mol Biol Rep; 2011 Feb; 38(2):939-48. PubMed ID: 20490690
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Effects of Migu Tablet on bone mineral density, serum levels of osteoprotegerin and its ligand and bone metabolic markers in patients with postmenopausal osteoporosis].
    Dai Y; Shen L; Yang YP
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2007 Aug; 27(8):696-9. PubMed ID: 17879531
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical study on effect of gushukang granule in preventing and treating primary osteoporosis].
    Li SQ; Pei ZG; Liu YM
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 2001 Apr; 21(4):265-8. PubMed ID: 12577353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of raloxifene hydrochloride on bone mineral density, bone metabolism and serum lipids in Chinese postmenopausal women with osteoporosis].
    Liu JL; Zhu HM; Huang QR; Zhang ZL; Li HL; Qin YJ; Zhang Y; Wei DL; Lu JH; Liu H; Chen XP; Liu YJ; Ekangaki A; Zheng YM; Diez-Perez A; Harpe K
    Zhonghua Yi Xue Za Zhi; 2004 Feb; 84(4):269-73. PubMed ID: 15059505
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of 17beta-estradiol at doses of 0.5, 1 and 2 mg compared with placebo on early postmenopausal bone loss in hysterectomized women.
    Giske LE; Hall G; Rud T; Landgren BM
    Osteoporos Int; 2002; 13(4):309-16. PubMed ID: 12030546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of teriparatide in increasing bone mineral density in postmenopausal women with osteoporosis--an Indian experience.
    Sethi BK; Chadha M; Modi KD; Kumar KM; Mehrotra R; Sriram U
    J Assoc Physicians India; 2008 Jun; 56():418-24. PubMed ID: 18822620
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effect of alendronate and MK-677 (a growth hormone secretagogue), individually and in combination, on markers of bone turnover and bone mineral density in postmenopausal osteoporotic women.
    Murphy MG; Weiss S; McClung M; Schnitzer T; Cerchio K; Connor J; Krupa D; Gertz BJ;
    J Clin Endocrinol Metab; 2001 Mar; 86(3):1116-25. PubMed ID: 11238495
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of transdermal estradiol delivered by a matrix patch on bone density in hysterectomized, postmenopausal women: a 2-year placebo-controlled trial.
    Arrenbrecht S; Boermans AJ
    Osteoporos Int; 2002; 13(2):176-83. PubMed ID: 11908492
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of low-dose alendronate treatment on bone mineral density and bone turnover markers in Chinese postmenopausal women with osteopenia and osteoporosis.
    Li M; Zhang ZL; Liao EY; Chen DC; Liu J; Tao TZ; Wu W; Xia WB; Lu YJ; Sheng ZF; Lu CY; Meng GL; Xu L; Zhang WJ; Hu YY; Xu L
    Menopause; 2013 Jan; 20(1):72-8. PubMed ID: 22968256
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical observation on treatment with the kidney-tonifying prescription in 25 cases of postmenopausal osteoporosis.
    Zhao G; Cai D; Dong S; Fan Y
    J Tradit Chin Med; 2003 Jun; 23(2):103-5. PubMed ID: 12875064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of raloxifene hydrochloride on bone mineral density, bone metabolism and serum lipids in Chinese postmenopausal women with osteoporosis: a multi-center, randomized, placebo-controlled clinical trial.
    Liu JL; Zhu HM; Huang QR; Zhang ZL; Li HL; Qin YJ; Zhang Y; Wei DL; Lu JH; Liu H; Chen XP; Liu YJ; Ekangaki A; Zheng YM; Diez-Perez A; Harper K
    Chin Med J (Engl); 2004 Jul; 117(7):1029-35. PubMed ID: 15265377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Ultralow-dose micronized 17beta-estradiol and bone density and bone metabolism in older women: a randomized controlled trial.
    Prestwood KM; Kenny AM; Kleppinger A; Kulldorff M
    JAMA; 2003 Aug; 290(8):1042-8. PubMed ID: 12941676
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Alendronate in postmenopausal women with osteopenia and osteoporosis: effects on bone mineral density during treatment and after withdrawal].
    Jiang Y; Li M; Xia W; Xing X; Yu W; Tian J; Meng X; Zhou X
    Zhonghua Yi Xue Za Zhi; 2002 Sep; 82(18):1254-6. PubMed ID: 12425805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effects of odanacatib on BMD and safety in the treatment of osteoporosis in postmenopausal women previously treated with alendronate: a randomized placebo-controlled trial.
    Bonnick S; De Villiers T; Odio A; Palacios S; Chapurlat R; DaSilva C; Scott BB; Le Bailly De Tilleghem C; Leung AT; Gurner D
    J Clin Endocrinol Metab; 2013 Dec; 98(12):4727-35. PubMed ID: 24064689
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Levonorgestrel and 17beta-estradiol given transdermally for the prevention of postmenopausal osteoporosis.
    Warming L; Ravn P; Christiansen C
    Maturitas; 2005 Feb; 50(2):78-85. PubMed ID: 15653003
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Clinical study on effect of bushen jiangu capsule on postmenopausal osteoporosis].
    Ding GZ; Zhang ZL; Zhou Y
    Zhongguo Zhong Xi Yi Jie He Za Zhi; 1995 Jul; 15(7):392-4. PubMed ID: 7580056
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Effects of Migu tablet on bone mineral density, serum matrix metalloproteinase-2 level and bone metabolic markers in postmenopausal osteoporosis].
    Dai Y; Shen L
    Zhongguo Zhong Yao Za Zhi; 2007 Nov; 32(22):2409-12. PubMed ID: 18257271
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevention of bone loss by clodronate in early postmenopausal women with vertebral osteopenia: a dose-finding study.
    Välimäki MJ; Laitinen K; Patronen A; Puolijoki H; Seppänen J; Pylkkänen L; Aranko SM; Sairanen S; Blåfield H; Rekiaro M; Väisänen K; Kormano M; Mäkinen L; Salmi J; Ala-Kaila K; Perttilä J; Vesterinen K; Koivunoro K;
    Osteoporos Int; 2002 Dec; 13(12):937-47. PubMed ID: 12459936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.